Colgate-Palmolive (NYSE:CL – Get Free Report) insider John W. Kooyman sold 3,497 shares of the company’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares in the company, valued at approximately $297,328.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Colgate-Palmolive Stock Up 0.7 %
CL stock traded up $0.62 during trading on Thursday, reaching $94.09. The stock had a trading volume of 4,639,516 shares, compared to its average volume of 4,693,216. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. The firm has a fifty day moving average price of $88.78 and a 200 day moving average price of $82.71. The company has a market capitalization of $77.20 billion, a P/E ratio of 29.77, a PEG ratio of 3.43 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $94.40.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The firm had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter in the prior year, the business posted $0.73 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 6.2% on a year-over-year basis. On average, equities analysts anticipate that Colgate-Palmolive will post 3.52 earnings per share for the current year.
Colgate-Palmolive Increases Dividend
Analysts Set New Price Targets
A number of equities research analysts have commented on CL shares. StockNews.com cut Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Barclays raised their target price on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 30th. Wells Fargo & Company raised their price objective on Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a report on Monday, April 29th. The Goldman Sachs Group assumed coverage on Colgate-Palmolive in a report on Friday, March 1st. They issued a “buy” rating and a $93.00 price target for the company. Finally, Bank of America boosted their target price on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday, April 29th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $91.44.
Check Out Our Latest Stock Report on Colgate-Palmolive
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the stock. Vest Financial LLC grew its stake in Colgate-Palmolive by 25.1% in the fourth quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after purchasing an additional 74,337 shares in the last quarter. Central Bank & Trust Co. increased its holdings in shares of Colgate-Palmolive by 22.1% in the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after acquiring an additional 250 shares during the last quarter. Dynamic Advisor Solutions LLC raised its position in shares of Colgate-Palmolive by 9.2% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock valued at $864,000 after acquiring an additional 910 shares in the last quarter. Sarasin & Partners LLP lifted its stake in Colgate-Palmolive by 1.2% during the fourth quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after purchasing an additional 49,980 shares during the last quarter. Finally, Cornerstone Wealth Management LLC lifted its stake in Colgate-Palmolive by 2.5% during the fourth quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after purchasing an additional 172 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- Canadian Penny Stocks: Can They Make You Rich?
- Roblox: The Bottom Just Fell Out of the Metaverse
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- What Are the U.K. Market Holidays? How to Invest and Trade
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.